Original Research
Published on 11 Nov 2025
Engineered NK92 cell-derived exosomes inhibit ovarian cancer progression by degrading GPRC5A
in Cancer Immunity and Immunotherapy
- 795 views
Original Research
Published on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Case Report
Published on 11 Nov 2025
in Hepatobiliary Diseases
Brief Research Report
Published on 11 Nov 2025
in Higher Education
Case Report
Published on 11 Nov 2025
in Obstetrics and Gynecology
Original Research
Published on 11 Nov 2025
in Educational Psychology
Original Research
Published on 11 Nov 2025
Original Research
Published on 11 Nov 2025
in Family Medicine and Primary Care
Original Research
Published on 11 Nov 2025
in Visceral Surgery
Original Research
Published on 11 Nov 2025
in Cognitive Neuroscience
Original Research
Published on 11 Nov 2025
in Epilepsy
Original Research
Published on 11 Nov 2025
in Ethnopharmacology
Editorial
Published on 11 Nov 2025
in Motor Neuroscience
Correction
Published on 11 Nov 2025
in Coronary Artery Disease
Editorial
Published on 11 Nov 2025
in Marine Geoscience
Editorial
Published on 11 Nov 2025
in Connected Health
Correction
Published on 11 Nov 2025
in Experimental Pharmacology and Drug Discovery